Global Patent Index - EP 3564264 B1

EP 3564264 B1 20210908 - VACCINE COMPOSITION COMPRISING A MUTANT OF HUMAN INTERLEUKIN-15

Title (en)

VACCINE COMPOSITION COMPRISING A MUTANT OF HUMAN INTERLEUKIN-15

Title (de)

IMPFSTOFF ENTHALTEND EINE IL-15 MUTANTE DES HUMANEN IL-15

Title (fr)

VACCINES CONTENANT UN MUTANT IL-15 DE L'INTERLEUKINE-15 HUMAINE

Publication

EP 3564264 B1 20210908 (EN)

Application

EP 17840472 A 20171220

Priority

  • CU 20160194 A 20161230
  • CU 2017050008 W 20171220

Abstract (en)

[origin: EP3564264A1] Vaccine composition containing a mutant of the human Interleukin-15 (IL-15). The use of said mutant polypeptide of human IL-15 to manufacture a medicament for the active immunotherapy of diseases associated with IL-15 overexpression, including some autoimmune diseases and hematological malignancies. Administration to an individual that needs it of a therapeutically effective amount of the vaccine, that comprises the mutant polypeptide of the human IL-15 of the invention, constitutes a method for the therapy of IL-15 over-expressing related diseases.

IPC 8 full level

C07K 16/24 (2006.01); A61K 39/00 (2006.01)

CPC (source: EP RU US)

A61K 39/00 (2013.01 - EP RU); A61K 39/00114 (2018.08 - EP RU US); A61K 39/39 (2013.01 - RU); A61P 29/00 (2018.01 - US); A61P 37/00 (2018.01 - RU); C07K 16/244 (2013.01 - EP US); A61K 2039/505 (2013.01 - EP US); A61K 2039/55505 (2013.01 - EP); A61K 2039/55538 (2013.01 - US)

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DOCDB simple family (publication)

EP 3564264 A1 20191106; EP 3564264 B1 20210908; BR 112019013542 A2 20200204; CN 110300762 A 20191001; CN 110300762 B 20230502; CU 20160194 A7 20180806; CU 24546 B1 20210907; ES 2892148 T3 20220202; MX 2019007906 A 20190904; RU 2019122635 A 20210201; RU 2019122635 A3 20210201; RU 2745199 C2 20210322; US 2020181254 A1 20200611; US 2022259300 A1 20220818; WO 2018121802 A1 20180705

DOCDB simple family (application)

EP 17840472 A 20171220; BR 112019013542 A 20171220; CN 201780086587 A 20171220; CU 20160194 A 20161230; CU 2017050008 W 20171220; ES 17840472 T 20171220; MX 2019007906 A 20171220; RU 2019122635 A 20171220; US 201716474913 A 20171220; US 202117531914 A 20211122